Large hypomethylated blocks as a universal defining epigenetic alteration in human solid tumors

Genome Medicine

Volumn 6, Issue 8, 2014, Pages

  Timp, Winston ^a,b   Bravo, Hector C ^c   McDonald, Oliver G ^a   Goggins, Michael ^a   Umbricht, Chris ^a   Zeiger, Martha ^a   Feinberg, Andrew P ^a   Irizarry, Rafael A ^a,d,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins University   (United States)

^c Department of Medicine Johns Hopkins University School of Medicine ^*  (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER TISSUE; COLON CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; LUNG CANCER; PANCREAS CANCER; PANCREATIC NEUROENDOCRINE TUMOR; SOLID TUMOR; THYROID CANCER;

EID: 84906837231     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/s13073-014-0061-y     Document Type: Article

References (27)

1. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983, 301:89-92. 10.1038/301089a0, 6185846.
2. Greger V, Passarge E, Hopping W, Messmer E, Horsthemke B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 1989, 83:155-158. 10.1007/BF00286709, 2550354.
3. Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 2009, 41:246-250. 10.1038/ng.297, 19151716.
4. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322. 10.1038/nature08514, 19829295.
5. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, Wen B, Wu H, Liu Y, Diep D, Briem E, Zhang K, Irizarry RA, Feinberg AP. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 2011, 43:768-775. 10.1038/ng.865, 21706001.
6. Berman BP, Weisenberger DJ, Aman JF, Hinoue T, Ramjan Z, Liu Y, Noushmehr H, Lange CP, van Dijk CM, Tollenaar RA, Van Den Berg D, Laird PW. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet 2012, 44:40-46. 10.1038/ng.969.
7. Hon GC, Hawkins RD, Caballero OL, Lo C, Lister R, Pelizzola M, Valsesia A, Ye Z, Kuan S, Edsall LE, Camargo AA, Stevenson BJ, Ecker JR, Bafna V, Strausberg RL, Simpson AJ, Ren B. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res 2012, 22:246-258. 10.1101/gr.125872.111, 22156296.
8. Hovestadt V, Jones DT, Picelli S, Wang W, Kool M, Northcott PA, Sultan M, Stachurski K, Ryzhova M, Warnatz HJ, Ralser M, Brun S, Bunt J, Jager N, Kleinheinz K, Erkek S, Weber UD, Bartholomae CC, von Kalle C, Lawrenz C, Eils J, Koster J, Versteeg R, Milde T, Witt O, Schmidt S, Wolf S, Pietsch T, Rutkowski S, Scheurlen W, et al. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature 2014, 510:537-541. 10.1038/nature13268, 24847876.
9. Hansen KD, Sabunciyan S, Langmead B, Nagy N, Curley R, Klein G, Klein E, Salamon D, Feinberg AP. Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization. Genome Res 2014, 24:177-184. 10.1101/gr.157743.113, 24068705.
10. Schroeder DI, Lott P, Korf I, LaSalle JM. Large-scale methylation domains mark a functional subset of neuronally expressed genes. Genome Res 2011, 21:1583-1591. 10.1101/gr.119131.110, 21784875.
11. Teschendorff AE, Jones A, Fiegl H, Sargent A, Zhuang JJ, Kitchener HC, Widschwendter M. Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation. Genome Med 2012, 4:24. 10.1186/gm323, 22453031.
12. Maegawa S, Gough SM, Watanabe-Okochi N, Lu Y, Zhang N, Castoro RJ, Estecio MR, Jelinek J, Liang S, Kitamura T, Aplan PD, Issa JP. Age-related epigenetic drift in the pathogenesis of MDS and AML. Genome Res 2014, 24:580-591. 10.1101/gr.157529.113, 24414704.
13. Nejman D, Straussman R, Steinfeld I, Ruvolo M, Roberts D, Yakhini Z, Cedar H. Molecular rules governing de novo methylation in cancer. Cancer Res 2014, 74:1475-1483. 10.1158/0008-5472.CAN-13-3042, 24453003.
14. Chelaru F, Smith L, Goldstein N, Chelaru F, Smith L, Goldstein N, Bravo HC: Epiviz: interactive visual analytics for functional genomics data. Nat Methods 2014, [epub ahead of print] doi:10.1038/nmeth.3038.
15. Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, Irizarry RA. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 2014, 30:1363-1369. 10.1093/bioinformatics/btu049, 24478339.
16. Jaffe AE, Murakami P, Lee H, Leek JT, Fallin MD, Feinberg AP, Irizarry RA. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol 2012, 41:200-209. 10.1093/ije/dyr238, 22422453.
17. McCall MN, Bolstad BM, Irizarry RA. Frozen robust multiarray analysis (fRMA). Biostatistics 2010, 11:242-253. 10.1093/biostatistics/kxp059, 20097884.
18. Bravo HC, Pihur V, McCall M, Irizarry RA, Leek JT. Gene expression anti-profiles as a basis for accurate universal cancer signatures. BMC Bioinformatics 2012, 13:272. 10.1186/1471-2105-13-272, 23088656.
19. Alemu EY, Carl JW, Corrada Bravo H, Hannenhalli S. Determinants of expression variability. Nucleic Acids Res 2014, 42:3503-3514. 10.1093/nar/gkt1364, 24435799.
20. Zilliox MJ, Irizarry RA. A gene expression bar code for microarray data. Nat Methods 2007, 4:911-913. 10.1038/nmeth1102, 17906632.
21. McCall MN, Uppal K, Jaffee HA, Zilliox MJ, Irizarry RA. The Gene Expression Barcode: leveraging public data repositories to begin cataloging the human and murine transcriptomes. Nucleic Acids Res 2011, 39:D1011-1015. 10.1093/nar/gkq1259, 21177656.
22. Cibas ES, Ali SZ. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol 2009, 132:658-665. 10.1309/AJCPPHLWMI3JV4LA, 19846805.
23. Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W, Eussen BH, de Klein A, Wessels L, de Laat W, van Steensel B. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 2008, 453:948-951. 10.1038/nature06947, 18463634.
24. McDonald OG, Wu H, Timp W, Doi A, Feinberg AP. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol 2011, 18:867-874. 10.1038/nsmb.2084, 21725293.
25. Coolen MW, Stirzaker C, Song JZ, Statham AL, Kassir Z, Moreno CS, Young AN, Varma V, Speed TP, Cowley M, Lacaze P, Kaplan W, Robinson MD, Clark SJ. Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity. Nat Cell Biol 2010, 12:235-246. 20173741.
26. Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell 2013, 153:38-55. 10.1016/j.cell.2013.03.008, 23540689.
27. Hojfeldt JW, Agger K, Helin K. Histone lysine demethylases as targets for anticancer therapy. Nat Rev Drug Discov 2013, 12:917-930. 10.1038/nrd4154, 24232376.